 | Up a level |
Berthold, F., Faldum, A., Ernst, A., Boos, J., Dilloo, D., Eggert, A., Fischer, M., Fruehwald, M., Henze, G., Klingebiel, T., Kratz, C., Kremens, B., Krug, B., Leuschner, I, Schmidt, M., Schmidt, R., Schumacher-Kuckelkorn, R., von Schweinitz, D., Schilling, F. H., Theissen, J., Volland, R., Hero, B. and Simon, T. (2020). Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR. Ann. Oncol., 31 (3). S. 422 - 430. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Corbacioglu, S., Lode, H., Escherich, G., Grigull, L., Hundsdoerfer, P., Steinbach, D., Schilling, F., Fruehwald, M., Greil, J., Gruhn, B., Ladenstein, R., Roessig, C. and Thorsten, S. (2016). RIST-RNB-2011: A Prospective Randomized Multicenter Trial of a Molecularly Targeted Multimodal Strategy for Patients with Relapsed and Refractory Neuroblastoma: An Update of the Ongoing Trial. Pediatr. Blood Cancer, 63. S. S209 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1545-5017
Nemes, K., Kachanov, D., Simon, T., Hauser, P., Tippelt, S., Woessmann, W., Flotho, C., Grigulls, L., Hernaiz-Driever, P., Schlegel, P. G., Abbink, F., Gi-da-Costa, M. J., Lowis, S., Hernandes Marquez, C., Graf, N., Nysom, K., Bens, S., Kroencke, T., Furtwaengler, R. and Fruehwald, M. (2018). Clinical and Genetic Risk Factors Define Two Risk Groups of Extracranial Rhabdoid Tumors: A Plea for High Risk Tailored Therapies. Pediatr. Blood Cancer, 65. S. S57 - 1. HOBOKEN: WILEY. ISSN 1545-5017